A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis

Details for Australian Patent Application No. 2003302889 (hide)

Owner Gambro Lundia AB

Inventors Linden, Torbjorn; Carlsson, Ola; Wieslander, Anders

Agent Griffith Hack

Pub. Number AU-B-2003302889

PCT Number PCT/SE2003/0019

PCT Pub. Number WO2004/052268

Priority 0203671-3 10.12.02 SE; 60/432,580 10.12.02 US

Filing date 10 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 11 September 2008

International Classifications

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/722 (2006.01)

A61K 31/726 (2006.01) - Glycosaminoglycans, i.e. mucopolysaccharides

Event Publications

29 July 2004 Complete Application Filed

  Priority application(s): 0203671-3 10.12.02 SE; 60/432,580 10.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003302889

11 September 2008 Application Accepted

  Published as AU-B-2003302889

22 January 2009 Standard Patent Sealed

10 November 2011 Assignment Registered

  Gambro Lundia AB The patent has been assigned to Fresenius Medical Care Deutschland GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302890-EXTERNALLY ACTIVATED NEUROIMPLANT WHICH DIRECTLY TRANSMITS THERAPEUTIC SIGNALS

2003302888-ORAL FORMULATIONS FOR POORLY ABSORPTIVE HYDROPHILIC DRUGS